Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,845 | 4,479 | N/A | N/A | N/A |
| Receivables | 14,648 | 12,090 | N/A | N/A | N/A |
| Inventories | 1,237 | 882 | N/A | N/A | N/A |
| TOTAL | $116,681 | $18,126 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,060 | 1,529 | N/A | N/A | N/A |
| Intangibles | 0 | 4 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,005 | 2,746 | 0 | 0 | 0 |
| TOTAL | $3,065 | $4,279 | $N/A | $N/A | $N/A |
| Total Assets | $119,746 | $22,405 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,833 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,865 | 1,451 | 0 | 0 | 0 |
| Accrued Expenses | 5,779 | 4,571 | N/A | N/A | N/A |
| TOTAL | $15,289 | $6,737 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,289 | 24,500 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 47,690 | 0 | 0 | 0 |
| TOTAL | $19,344 | $72,234 | $N/A | $N/A | $N/A |
| Total Liabilities | $34,633 | $78,971 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,192 | N/A | N/A | N/A | N/A |
| Common Shares | 17 | 2 | N/A | N/A | N/A |
| Retained earnings | -52,212 | -57,489 | N/A | N/A | N/A |
| TOTAL | $85,113 | $-56,566 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $119,746 | $22,405 | $0 | $0 | $0 |